characteristics are associated with a successful response to treatment for
hepatitis C virus (HCV) in people with HIV co-infection, Spanish researchers report in the online edition of AIDS. The study involved people with the difficult-to-treat HCV genotypes 1
and 4, who received dual therapy with pegylated interferon and ribavirin.
response rate was almost 80% for participants with the most
favourable genetic profile compared to a response rate of just 7% for
people with the least favourable profile. The investigators hope their
help doctors and patients predict the likely outcome of HCV therapy